Literature DB >> 20009882

Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patients.

Marion Fournier1, Eberhard Stoeckle, Frédéric Guyon, Véronique Brouste, Laurence Thomas, Gaëtan MacGrogan, Anne Floquet.   

Abstract

OBJECTIVES: To perform a cartography of lymph node metastases in epithelial ovarian cancer and to determine predictive factors of lymph node metastases.
METHOD: The charts of 355 patients with epithelial ovarian cancer who underwent lymphadenectomy during a primary (n = 252) or secondary debulking surgery (n = 103) were analyzed. The topography of the lymph node metastases was notified for the whole group according to the stage of the disease, the histological type, and the moment of surgery. In patients who underwent a primary surgery before chemotherapy, independent prognostic variables for the risk of lymph node involvement were tested with a multivariate analysis. Independent prognostic factors were combined to determine risk profiles in individual patients.
RESULTS: The main area of the lymph node metastases was para-aortic. Isolated pelvic lymph node involvement was 10%. Three variables independently predicted lymph node invasion: advanced T stage, high-risk histological profile, and metastases.
CONCLUSIONS: When lymphadenectomy is recommended, systematic lymph node dissections in the aortic and pelvic areas are warranted. An isolated pelvic lymph node assessment, particularly in the early stages, is inappropriate. By combining independent risk factors, a useful tool for individual risk assessment of lymph node involvement could be established, helping to decide whether to perform a lymph node dissection, especially at restaging surgery.

Entities:  

Mesh:

Year:  2009        PMID: 20009882     DOI: 10.1111/IGC.0b013e3181b8a07c

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers.

Authors:  K D Swenerton; J L Santos; C B Gilks; M Köbel; P J Hoskins; F Wong; N D Le
Journal:  Ann Oncol       Date:  2010-08-06       Impact factor: 32.976

2.  Sentinel node in ovarian cancer: study protocol for a phase 1 study.

Authors:  Marjolein Kleppe; Toon Van Gorp; Brigitte F M Slangen; Arnold J Kruse; Boudewijn Brans; Ivo N A Pooters; Koen K Van de Vijver; Roy F P M Kruitwagen
Journal:  Trials       Date:  2013-02-15       Impact factor: 2.279

3.  Role of lymphadenectomy for ovarian cancer.

Authors:  Mikio Mikami
Journal:  J Gynecol Oncol       Date:  2014-10       Impact factor: 4.401

4.  Understanding Lymphatic Drainage Pathways of the Ovaries to Predict Sites for Sentinel Nodes in Ovarian Cancer.

Authors:  Marjolein Kleppe; Anne C Kraima; Roy F P M Kruitwagen; Toon Van Gorp; Noeska N Smit; Jacoba C van Munsteren; Marco C DeRuiter
Journal:  Int J Gynecol Cancer       Date:  2015-10       Impact factor: 3.437

5.  Metastasis to para-aortic lymph nodes cephalad to the renal veins in patients with ovarian cancer.

Authors:  Shinichi Komiyama; Masaru Nagashima; Tomoko Taniguchi; Takayuki Rikitake; Mineto Morita
Journal:  World J Surg Oncol       Date:  2020-04-01       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.